Show simple item record

dc.contributor.advisorNeelotpol, Dr. Sharmind
dc.contributor.authorHasnat, Najib
dc.date.accessioned2018-01-09T07:01:15Z
dc.date.available2018-01-09T07:01:15Z
dc.date.copyright2017
dc.date.issued2017-07
dc.identifier.otherID 12146033
dc.identifier.urihttp://hdl.handle.net/10361/8986
dc.descriptionThis project report is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2017.en_US
dc.descriptionCataloged from PDF version of project report.
dc.descriptionIncludes bibliographical references (page 21-24).
dc.description.abstractMyriad lines of therapy are used to treat cancer around the world. The study was conducted on the patients of National Institute of Cancer Research (NICRH) to estimate which type of anticancer drugs are mostly being used to treat selected type of cancer (breast, cervix and throat cancer). The study was based upon two sections- literature review and cross-sectional questionnaire study design. The aim of the study is compare the therapeutic efficacy of plant and synthetic origin of anticancer drugs on the basis of their mode of action. The data taken from the literature review was used to form a list of questions; accordingly a set of variables were developed to use in the questionnaire. As the representatives of the two classes of drugs, cisplatin was selected for the platin based synthetic alkylating agents; paclitaxel was selected for the taxane and vinca alkaloid type of plant derivatives. The platin-based alkylating agents were mostly used in most of these cases while the breast cancer (36%) and cervical cancer (36%) patients were abundant in number. Cisplatin based drugs were used in both cases while antibiotics were used in treating throat cancer. The study did not put up enough evidence for the efficacy of the plant derivatives of anticancer agents (taxanes, vinca alkaloids) however, they do show major improvements in accord to the theoretical data gained from the literature.en_US
dc.format.extent27 pages
dc.language.isoenen_US
dc.publisherBRAC Univeristyen_US
dc.rightsBRAC University project reports are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectAnticancer drugen_US
dc.subjectSynthetic derivativeen_US
dc.subjectCanceren_US
dc.subjectNICRHen_US
dc.titlePractice of using plant and synthetic derivatives of anticancer drugs among cancer patients at NICRH, Bangladeshen_US
dc.typeProject reporten_US
dc.contributor.departmentDepartment of Pharmacy, BRAC University
dc.description.degreeB. Pharmacy


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record